Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Sichuan Biokin Pharmaceutical Co Ltd (SBP12 HK)
Watchlist
1
Analysis
Health Care
•
Hong Kong
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Nexchip Semiconductor
•
21 Dec 2023 06:20
STAR50 Index Rebalance Preview: Four High Impact Changes in March
There could be 4 changes for the STAR50 Index in March. Passive trackers will need to trade between 1.2-9.7x ADV on the adds/dels. There will be...
Brian Freitas
Follow
762 Views
Share
bearish
•
Shanghai Haoyuan Chemexpress C
•
17 Dec 2023 09:21
China Healthcare Weekly (Dec.15)-BMS/Biokin $8.4B Eye-Popping Deal, NRDL Negotiation Result, Haoyuan
2023 NRDL negotiation result is released, policy for innovative drugs become more friendly. BMS-Biokin $8.4B deal is record-breaking, but with...
Xinyao (Criss) Wang
Follow
472 Views
Share
bullish
•
Hygon Information Technology C
•
07 Dec 2023 07:12
China: Consolidated Flows at the Close Tomorrow
Local indices in China rebalance tomorrow and we estimate passives will need to trade around CNY 54bn (US$7.5bn). There will be big impact on some...
Brian Freitas
Follow
443 Views
Share
bullish
•
Uber Technologies
•
03 Dec 2023 05:40
Index Rebalance & ETF Flow Recap: KWEB, CSI300/500, STAR50, SSE50, ChiNext, SET50, Chips, Denso, SPX
This recap highlights Insights covering Asian index rebalances (announcements/ forecasts/ IPO Fast Entry/ M&A driven changes). We also highlight...
Brian Freitas
Follow
546 Views
Share
bearish
•
Ninebot
•
13 Nov 2023 07:32
STAR50 Index Rebalance Preview: Big Impact Expected on the Changes
There could be 1 index change in Dec. The ETF inflows over the last few months results in passives needing to trade 9-25x ADV on the add/delete....
Brian Freitas
Follow
532 Views
Share
First
Previous
1
2
3
4
5
Next
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.37.3
x